Leptin, hs-CRP, IL-18 and urinary protein before and after treatment of children with nephrotic syndrome

Zhou,Jiayun; Shi,Feng; Xun,Wenlong

doi:10.3892/etm.2018.5923

Leptin, hs-CRP, IL-18 and urinary protein before and after treatment of children with nephrotic syndrome

Authors:
- Jiayun Zhou
- Feng Shi
- Wenlong Xun
View Affiliations

Affiliations: Department of Pediatrics, People's Hospital of Rizhao, Rizhao, Shandong 276800, P.R. China
Published online on: March 5, 2018 https://doi.org/10.3892/etm.2018.5923
Pages: 4426-4430
Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

We aimed to analyze the changes in plasma leptin, serum inflammatory factors and urinary protein in children with nephrotic syndrome before and after treatment and their clinical significance. A total of 28 children treated and diagnosed with nephrotic syndrome between November 2015 and October 2016 were selected as treatment group, while 25 healthy children were selected as control group. There were no statistically significant differences in age, sex, body mass index (BMI), serum albumin and other general data between treatment group and control group (P>0.05). There was a positive correlation between serum high-sensitivity C-reactive protein (hs-CRP) level and 24 h urinary protein level in children with nephrotic syndrome before treatment (r=0.408, P=0.005). Twenty-four hours urinary protein, urea nitrogen (BUN) and serum creatinine (SCr) levels in children with nephrotic syndrome before treatment were significantly higher than those in normal children, and these indexes were significantly decreased after treatment. The levels of plasma leptin and serum inflammatory factors (hs-CRP and IL-18) in children with nephrotic syndrome before treatment were obviously higher than those in normal children, and these indexes were obviously decreased after treatment. In conclusion, the detection of changes in plasma leptin, serum inflammatory factors (hs-CRP and IL-18) and urinary protein in children with nephrotic syndrome before and after treatment has important reference value for reflecting the severity of disease and evaluating the prognosis of children with nephrotic syndrome.

View Figures

View References

1	Landt M, Ludbrook PA and Billadello JJ: Role of protein binding in renal elimination of leptin. Clin Endocrinol (Oxf). 59:44–48. 2003. View Article : Google Scholar : PubMed/NCBI
2	Yao H, Cai ZY and Sheng ZX: NAC attenuates adriamycin-induced nephrotic syndrome in rats through regulating TLR4 signaling pathway. Eur Rev Med Pharmacol Sci. 21:1938–1943. 2017.PubMed/NCBI
3	Daschner M, Tönshoff B, Blum WF, Englaro P, Wingen AM, Schaefer F, Wühl E, Rascher W and Mehls O: European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood: Inappropriate elevation of serum leptin levels in children with chronic renal failure. J Am Soc Nephrol. 9:1074–1079. 1998.PubMed/NCBI
4	Yoshida T, Momotani N, Hayashi M, Monkawa T, Ito K and Saruta T: Serum leptin concentrations in patients with thyroid disorders. Clin Endocrinol (Oxf). 48:299–302. 1998. View Article : Google Scholar : PubMed/NCBI
5	Bakr A, Shokeir M, El-Chenawi F, El-Husseni F, Abdel-Rahman A and El-Ashry R: Tumor necrosis factor-alpha production from mononuclear cells in nephrotic syndrome. Pediatr Nephrol. 18:516–520. 2003.PubMed/NCBI
6	Florian M, Florianova L, Hussain S and Magder S: Interaction of estrogen and tumor necrosis factor alpha in endothelial cell migration and early stage of angiogenesis. Endothelium. 15:265–275. 2008. View Article : Google Scholar : PubMed/NCBI
7	Matsumoto K and Kanmatsuse K: Elevated interleukin-18 levels in the urine of nephrotic patients. Nephron. 88:334–339. 2001. View Article : Google Scholar : PubMed/NCBI
8	Drewe E, McDermott EM and Powell RJ: Treatment of the nephrotic syndrome with etanercept in patients with the tumor necrosis factor receptor-associated periodic syndrome. N Engl J Med. 343:1044–1045. 2000. View Article : Google Scholar : PubMed/NCBI
9	Reinehr T, Kratzsch J, Kiess W and Andler W: Circulating soluble leptin receptor, leptin, and insulin resistance before and after weight loss in obese children. Int J Obes. 29:1230–1235. 2005. View Article : Google Scholar
10	Lányi E, Csernus K, Erhardt E, Tóth K, Urbán B, Lénárd L and Molnár D: Plasma levels of acylated ghrelin during an oral glucose tolerance test in obese children. J Endocrinol Invest. 30:133–137. 2007. View Article : Google Scholar : PubMed/NCBI
11	Schroth M, Kratzsch J, Gröschl M, Rauh M, Rascher W and Dötsch J: Increased soluble leptin receptor in children with nephrotic syndrome. J Clin Endocrinol Metab. 88:5497–5501. 2003. View Article : Google Scholar : PubMed/NCBI
12	Schroth M, Gröschl M, Dörr HG, Blum WF, Rascher W and Dötsch J: Renal loss of leptin in patients with nephrotic syndrome. Eur J Endocrinol. 145:463–468. 2001. View Article : Google Scholar : PubMed/NCBI
13	Garcia GE, Xia Y, Ku G, Johnson RJ, Wilson CB and Feng L: IL-18 translational inhibition restricts IFN-gamma expression in crescentic glomerulonephritis. Kidney Int. 64:160–169. 2003. View Article : Google Scholar : PubMed/NCBI
14	Nguyen MT and Devarajan P: Biomarkers for the early detection of acute kidney injury. Pediatr Nephrol. 23:2151–2157. 2008. View Article : Google Scholar : PubMed/NCBI
15	Washburn KK, Zappitelli M, Arikan AA, Loftis L, Yalavarthy R, Parikh CR, Edelstein CL and Goldstein SL: Urinary interleukin-18 is an acute kidney injury biomarker in critically ill children. Nephrol Dial Transplant. 23:566–572. 2008. View Article : Google Scholar : PubMed/NCBI
16	Araya C, Diaz L, Wasserfall C, Atkinson M, Mu W, Johnson R and Garin E: T regulatory cell function in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol. 24:1691–1698. 2009. View Article : Google Scholar : PubMed/NCBI
17	Wakkach A, Augier S, Breittmayer JP, Blin-Wakkach C and Carle GF: Characterization of IL-10-secreting T cells derived from regulatory CD4⁺CD25⁺ cells by the TIRC7 surface marker. J Immunol. 180:6054–6063. 2008. View Article : Google Scholar : PubMed/NCBI
18	Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, de Waal-Malefyt R, Coffman RL, Hawrylowicz CM and O'Garra A: In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med. 195:603–616. 2002. View Article : Google Scholar : PubMed/NCBI
19	Kiliś-Pstrusińska K, Medyńska A, Zwolińska D and Wawro A: Interleukin-18 in urine and serum of children with idiopathic nephrotic syndrome. Kidney Blood Press Res. 31:122–126. 2008. View Article : Google Scholar : PubMed/NCBI